Primary Site >> Esophagus Cancer

Gene >> TAOK2

  • 1988
  • 1995
  • 1998
  • 2000
  • 2006
  • 2009
  • 2012
Ref: [Evaluation of immunotherapy with PSK in esophageal cancer].
PMID: 3056280
Ref: Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan.
PMID: 7627722
Ref: Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
PMID: 7747709
Ref: A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).
PMID: 9457474
Ref: The use of mushroom glucans and proteoglycans in cancer treatment.
PMID: 10696116
Ref: [A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy].
PMID: 16484862
Ref: [PSK-mediated growth suppression and enhancement of 5-FU/docetaxel-induced cytotoxicity in human esophageal cancer cell lines].
PMID: 20037295
Ref: PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells.
PMID: 22552778